CORPORATE PRESENTATION NOVEMBER 2019 Long-term Success in Cannabis - - PowerPoint PPT Presentation

corporate presentation
SMART_READER_LITE
LIVE PREVIEW

CORPORATE PRESENTATION NOVEMBER 2019 Long-term Success in Cannabis - - PowerPoint PPT Presentation

CSE : CGOC CORPORATE PRESENTATION NOVEMBER 2019 Long-term Success in Cannabis Investing cgocorp.com 1 Disclaimer The presented materials and accompanying oral presentation may constitute forward -looking information within the meaning


slide-1
SLIDE 1

cgocorp.com 1

CSE : CGOC

NOVEMBER 2019

CORPORATE PRESENTATION

Long-term Success in Cannabis Investing

slide-2
SLIDE 2

cgocorp.com 2

Disclaimer

The presented materials and accompanying oral presentation may constitute “forward-looking information” within the meaning of Canadian securities laws and are based on expectations, estimates and projections as of the date of this presentation. Forward-looking statements include, without limitation, statements with respect to: a) the completion of the Offering and receipt of all regulatory approvals in connection therewith; b) the use of the net proceeds of the Offering; c) the availability of investment opportunities; d) the performance of the Corporation’s business and operations; e) applicable laws, regulations and any amendments thereof including, but not limited to, the legalization of cannabis and the timing thereto; f) the competitive and business strategies of the Corporation; g) statements related to the effect and consequences of certain regulatory initiatives; h) the expected growth of the cannabis sector; i) the competitive conditions of the industry; j) the Corporation’s investments in the U.S. and consequences of those investments under U.S. federal law; and k) the anticipated changes to laws regarding the recreational use of cannabis and the business impacts on the Corporation Forward-looking statements are necessarily based upon management’s perceptions of historical trends, current conditions and expected future developments, as well as a number of specific factors and assumptions that, while considered reasonable by management as of the date on which the statements are made in this presentation, are inherently subject to significant business, economic and competitive uncertainties and contingencies which could result in the forward-looking statements ultimately being incorrect. In addition to the various factors and assumptions set forth in this presentation, the material factors and assumptions used to develop the forward-looking information include, but are not limited to: general economic, financial market, regulatory and political conditions in which the Corporation operates will continue to improve; the Corporation will be able to compete in the industry; the Corporation will be able to make investments on suitable terms; issuers in the Portfolio will be able to meet their objectives and financial estimates and that the risk factors noted below, collectively, do not have a material impact on the Corporation.

By its nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. Known and unknown risk factors, many of which are beyond the control of the Corporation could cause actual results to differ materially from the forward-looking information in this presentation. Such factors, without limitation, include the following, which are discussed in greater detail in the “Risk Factors” section of the Prospectus: there is no assurance that the Corporation will be able to achieve its investment objectives; risks relating to the Portfolio issuers; risks relating to medical cannabis; risks relating to risk and timing of legalization of recreational cannabis; regulatory risks; risks relating to the performance of the Portfolio issuers; risks relating to the licensing process; no current market for Common Shares or Warrants; risks relating to recent and future global financial developments; industry concentration risks; risks associated with investment in illiquid and private securities; risk factors related to U.S. cannabis legislation; changes to the cannabis laws; United States anti-money laundering laws and regulations; investments in U.S. cannabis sector; short selling; use of the Prime Broker to hold assets; sensitivity to interest rates; reliance on the Manager and Investment Manager; conflicts of interest; risks related to dilution; loss of investment; risks relating to currency exposure; risks relating to foreign market exposure; lack of operating history; risks related to the exchange option; and tax risks. These risk factors are not intended to represent a complete list of the factors that could affect the Corporation and investors are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking statements. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Forward-looking statements are provided for the purpose of providing information about management’s expectations and plans relating to the future. The Corporation disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or

  • therwise, or to explain any material difference between subsequent actual events and such forward-looking statements, except to the extent required by applicable law.

Terms undefined herein have the meanings ascribed to them in the Prospectus. An investor should rely only on the information contained in the Prospectus. This presentation is qualified in its entirety by reference to, and must be read in conjunction with, the detailed information appearing in the Prospectus. Neither the Corporation nor the Agent has authorized anyone to provide investors with different or additional information. The Corporation is not offering, or soliciting offers to acquire, the securities in any jurisdiction in which the offer is not permitted. For purchasers outside Canada, neither the Corporation nor the Agent have done anything that would permit the offering or distribution of this presentation together with the Prospectus in any jurisdiction where action for that purpose is required, other than in Canada. An investor is required to inform itself about and to observe any restrictions relating to the planned public offering and the distribution of this presentation and of the Prospectus. No securities regulatory authority has expressed an opinion about the securities of the Corporation discussed in this presentation and it is an offence to claim otherwise. The securities of the Corporation discussed in this presentation have not been, and will not be, registered under the U.S. Securities Act, or the securities laws of any state of the United States and, subject to certain exceptions, may not be offered, sold or delivered, directly or indirectly, in the United States except pursuant to an exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws. This presentation does not constitute an offer to sell or solicitation of an offer to buy any of the securities of the Trust in the United States. An investment in the securities offered by the Prospectus must be considered speculative as the securities are subject to certain risk factors as set out under the heading “Risk Factors” in the Prospectus or otherwise described in the Prospectus. An investment in Units of the Corporation is appropriate only for investors who have the capacity to absorb a loss of some or all of their investment. Investors should also review the financial statements included in the Prospectus.

cgocorp.com 2

slide-3
SLIDE 3

cgocorp.com 3

Our Vision Our goal was to create a vehicle that would take the guess work out of cannabis investing, and create an easy, less volatile entry point for new investors into this rapidly growing and fast changing sector

  • We ha

have ma made de th the ri right ht de deci cisi sion

  • ns

s to s

  • sta

tay ahe head d of

  • f th

the c cur urve

  • We ha

have ta taken a n a p prud udent nt a app pproa

  • ach

ch to to ou

  • ur pr

priv ivat ate po portfol

  • lio,

io, wh where we n now s w see si sign gnif ific icant nt ga gain ins pa s payin ing of g off

  • We ha

have cr creat ated a v d a vehi hicl cle su suite ited f d for

  • r no

not on

  • nly the

he a average age retail il in investor stor, bu but for for any nyon

  • ne lo

look

  • kin

ing g for

  • r true

ue di diversi sific ficati ation

  • n in

in c cann nnabi bis s in in or

  • rde

der to ac to achi hieve lo long ng-term m su succ ccess ss

slide-4
SLIDE 4

cgocorp.com 4

Our Value Proposition

Lon

  • ng-term

erm Suc ucces cess s in in Can Cannab nabis is

Div iversif rsific ication: ion: A diversified and actively managed portfolio

investing in both public and private cannabis companies globally

Gate Gateway y to to the he US: S: Ability to take advantage of significant

valuation discrepancies with early access into US private companies

Gl Glob

  • bal

l Reach: ch: Ability to invest globally and be a first mover in the

global emerging markets

Sm Smart Capi pital al: : Pre-IPO deal flow through our network effect –

supporting sustainable deal flow from the extended network

slide-5
SLIDE 5

cgocorp.com 5

The Cannabis Industry Opportunity Can annabis nabis Val alue ue Cha hain in

Supplie liers rs Pr Prod

  • duc

uction tion Con

  • nsu

sumer er Pr Prod

  • duc

ucts ts Retail il & & Dis istrib ibutio ution Se Services ices

Cannab nabinoid inoid Therap rapeutics utics

Fin inance nce Real l Est Estate Hemp Pr Prod

  • duc

ucts ts

CGOC has also invested in

Traditional Industry

Investing across the ecosystem multiplies the potential

slide-6
SLIDE 6

cgocorp.com 6

US Investments CGOC is your gateway to the US cannabis market

  • Unique access to private US Cannabis investment opportunities
  • Strong industry connections providing proprietary deal flow
  • CGOC Network Effect in full force south of the border

Private US Investments across 18 states

slide-7
SLIDE 7

cgocorp.com 7

The CGOC Network Effect

CG CGOC OC

Creating value that results in proprietary deal flow

In Investors stors Priv ivat ate Co’s Pub ubli lic c Co’s

Gain exposur sure to to mor

  • re

so sophi histi sticated d inst stit ituti ution

  • nal

sh shareh ehol

  • lders

ders Gain name exposur

  • sure

to to public mark rkets ts Partne tnershi rships ps and M& M&A o A oppor portuniti ities

Ga Gain ac acces ess to

  • prof
  • fes

essional

  • nally

man anaged ged diver ersifi ified ed por

  • rtf

tfol

  • lio

io Ga Gain ac acces ess to private e inves estme tment nts s

Gain st strateg egic advi visor sory y from

  • m CGO

GOC

slide-8
SLIDE 8

cgocorp.com 8

CGOC:CSE

Portfolio Overview

  • Geographic Breakdown
  • Top 10 Public & Private Investments
slide-9
SLIDE 9

cgocorp.com 9

Portfolio Breakdown CGOC helps bring access to key investments in Canada, USA and International markets, driven by its private portfolio.

*Portfolio breakdown at cost

Ge Geog

  • grap

raphic hical al Br Break eakdo down wn of

  • f P

Public c an and Priv ivate e Por

  • rtf

tfol

  • lio

ios Br Break eakdown wn of

  • f I

Investment estment Sp Split t ac acros

  • ss

the Public and Private Portfolio’s

41% 59% 0% 27% 27% 41% 41% 32% 32%

Percentage of Private Portfolio

US Canadian International 60% 60% 38% 38% 2% 2%

Percentage of Public Portfolio

US Canadian International

slide-10
SLIDE 10

cgocorp.com 10

Managing the Public Portfolio 2017 -2018

Funded Capacity and Rec

2015-2016

Cultivation and Medical

2019 and Beyond

Extracted Products, CPG, R.O.W.

2018 -2019

Rec and Supply Agreements, USA

Evolution of the Portfolio

slide-11
SLIDE 11

cgocorp.com 11

Upcoming Catalysts Areas to Watch

Canada

  • Sales – Ramp Up, Retail, Products
  • Extracted Product Regulations – Who is ready, Who will lead?
  • M&A – Size, Strategy, Diversification

United States

  • CBD – Hype or Dwindle
  • Legislation SAFE and STATEs – What do they mean to the portfolio
  • M&A – Inside and outside the Boarders

International

  • Europe, Australia, South America
slide-12
SLIDE 12

cgocorp.com 12

Top 10 Public Investments

A diversified portfolio of public companies focused on maximizing long-term

  • growth. The public portfolio is actively managed by a seasoned Portfolio Manager,

with a focus of staying ahead of the curve.

CSE: BHNG (USA SA) Award winning house of cannabis & hemp brands Not yet list sted ed (USA) Vertically integrated producer in California CSE: CXXI (USA SA) Vertically integrated producer of cannabis and hemp derived consumer products CSE: NGW (USA SA) Vertically integrated producer, known as one of California’s best consumer packaged goods brands Not yet list sted ed (USA) Grassroots is focused on vertical integration in limited licensed medical markets CSE: PL PLTH H (USA SA) Vertically integrated cannabis company based in Nevada, (Planet 13 Cannabis Entertainment Complex) CSE: CANN (Cana anada da) Vertically integrated cannabis provider CSE: TER ER (Cana anada da) Provides quality products, brands and services to global cannabinoid market NEX EX: JU JUSH.B (USA SA) Building a vertically integrated MSO of cannabis and hemp licenses TSX-V: : VIVO (Cana anada da) Pharma and recreational

slide-13
SLIDE 13

cgocorp.com 13

Private Portfolio Investments

Our private portfolio companies have seen enormous success and have and continue to positively impact our NAV.

. Canada da Merchant bank, actively investing in new and innovative US enterprises Canada da & US US Cannabis wellness and lifestyle brand North th Maced acedonia

  • nia

Producer of premium medical cannabis products for European markets US (Cali alifornia

  • rnia)

Creating biologically active and nutrient dense biochar soils for commercial agriculture Canada da (Quebec) ec) World-class cannabis centre site, supporting cannabis innovators Canada da Supporting many top tier brands in cannabis US US Facilitates partnerships between farmers and consumers Canada da Consumer healthcare with products under the brand SannaTM

TM

Canada da LP furthering the science of medical cannabis Canada da A vertically integrated producer & distributor Jamai maica Lowest cost producers globally, located in an ideal natural climate Israel ael Agri-Co licensed to produce and supply medical cannabis Canada da (Aura Cannabis) An independent Canadian cannabis retailer US (Cali alifornia

  • rnia)

vertically integrated direct-to consumer Canada/ da/ Israel ael Development and commercialization of pharmaceutical cannabis Canada da Next generation R&D biopharmaceutical company US (Cali alifornia

  • rnia)

Application software connecting users with lifestyle brands Switz tzer erlan and Biodynamic agriculture creating sustainable

  • rganically grown cannabis

products Canada da Merchant bank, actively investing in new and innovative US enterprises

slide-14
SLIDE 14

cgocorp.com 14

Private Portfolio – Recent and Pending Events

RECENT GO PUBLIC TRANSACTION IM Cannabis Corp (formerly I.M.C. Holdings Ltd.) completed its RTO transaction and listed on the CSE under the symbol “IMCC”, on November 5, 2019, and closed its first day of trading at $0.63. CGOC invested $250,000 CAD in IMCC in May of 2018, receiving 62,500 common shares and 31,250 warrants.

IM Cannabis is a leading medical cannabis provider. Since 2010, the company has offered a full spectrum of government- licensed cannabis products, from generic to GMP-certified and pharmaceutical-grade, for both wholesale and retail clients. IMCC is an industrial innovator, constantly moving forward in the rapidly developing medical cannabis market and closely collaborating with research institutions and start-up companies. IMCC is based in Israel & expanding internationally, currently focusing on the EU market. IMC initiated its strategy by acquiring a pharmaceutical distribution company in Germany with all licenses required for distribution of medical cannabis throughout Europe. IMC’s supply of EU-GMP pharma-grade medical cannabis products is available from a variety of sources, both EU cultivation farms, as well as Israeli farms. IMC has formed strong strategic alliances within the international medical cannabis industry and has developed a long-term, IP-protected product portfolio.

slide-15
SLIDE 15

cgocorp.com 15

Private Portfolio – Case Study of Meaningful Acquisitions

Feb/ 2018 - investment of $450,000 for 175,000 shares at $2.75 per share. May 30/2018 Harvest One acquired DreamWater for a combination of cash and shares with a total value of $34.5 million.

ROI I of

  • f 55

55% in in 3 3 m mon

  • nths

hs

Apr/2018 – investment of $2,009,000 for 205 common shares at $9,800 per share. On March 4, 2019, Aurora Cannabis completed the acquisition of Whistler Medical payable in three tranches, subject to certain milestones.

Total l ROI I wi will ll be be c calc lcul ulat ated d

  • n
  • nce

ce fin inal l tr tranc nche he is pa is paid id

slide-16
SLIDE 16

cgocorp.com 16

Private Portfolio – Case Study of Meaningful Liquidity Events

Aug/ 2018 – Initial investment of $750,000 for 1,250,000 unites at $0.60 per unit. Completed its RTO transaction to commence trading on the CSE under the symbol “NGW”, on Oct/10/2018 Divested of 11%, remainder is still held in public portfolio.

ROI I of

  • f 3

38% % in 3 mon months ths ROI I of

  • f 1

188% 8% in 9 mon

  • nth

ths

Jul/ 2018 – Initial investment of $1,971,710 for 33,500 units at $57.23 per unit. Vireo completed its RTO transaction and commenced trading on the CSE under the symbol “VREO”, on March 20, 2019 at an opening price of $5.65 (units converted at exchange ratio of 30.0048 into 1,005,161 common shares) . Still held in the public portfolio Mar/ 2018 – Initial investment of $1,962,090 for 1,500,000 common shares & 1,500,000 Warrants. Jushi completed its RTO transaction and commenced trading on the NEO Exchange under the symbol “ JUSH.B”,

  • n June 10, 2019 at a closing price of

$3.20 (only common shares taken into account in ROI calculation). Still held in the public portfolio

ROI I of

  • f 1

178% 8% in 15 mon

  • nth

ths

slide-17
SLIDE 17

cgocorp.com 17

CGOC:CSE

Valuation & Performance

  • Overview of CGOC performance over time
slide-18
SLIDE 18

cgocorp.com 18

Valuation & Performance

  • NAV

V as s of Nov/15 v/15 = $2 $2.5 .51 1 perform

  • rming

ng well against st our benchma hmarks rks

  • NAV

V decrea ease se of 9% 9% YTD TD

  • NAV

V increase se of 8% 8% si since inception

  • n

*HMJR from February 14, 2018, **Jan 26 starting NAV after agent’s fee $2.3171

CGOC strategy has resulted in portfolio gains and reduced downside through industry volatility

  • 0.4
  • 0.3
  • 0.2
  • 0.1

0.1 0.2 0.3 Sep 17 VS Aug 13 Oct 15 VS Sep 17 Nov 15 VS Oct 15 Dec 17 VS Nov 15 Jan 15 VS Dec 17 Feb 15 VS Jan 15 Mar 15 VS Feb 15 Apr 15 VS Mar 15 May 15 VS Apr 15 June 14 VS May 15 July 15 VS June 14 August 15 VS July 15 Sept 16 VS Aug 15 Oct15 VS Sept 16 HMMJ HMJR NAMMAR CGOC NAV November 15 VS Inception

  • 61%
  • 71%
  • 67%

8%

  • 61%

61%

  • 71%

71%

  • 67%

67% 8% 8%

slide-19
SLIDE 19

cgocorp.com 19

CGOC Share Price Return CGOC has outperformed YTD, however recent downward pressure has affected the market as a whole.

slide-20
SLIDE 20

cgocorp.com 20

CGOC:CSE

Summary

CG CGOC OC.C .COM OM

  • Additional catalyst events within the private portfolio should

positively impact the NAV going forward and demonstrate the opportunity available for investors

  • Exposure to both private and public companies with better

liquidity than investing directly into the privates

  • Global Focus – early participation in emerging cannabis

markets (such as Europe)

  • Smart Capital – we are offered proprietary deal flow
slide-21
SLIDE 21

cgocorp.com 21

CGOC:CSE

APPENDIX

slide-22
SLIDE 22

cgocorp.com 22

The CGOC Team

Experienced leadership and operational team

Sean Conache nacher Director, CEO Ex Experi rience enced d and d demons nstra trated ed leade der workin ing in the fi finan ancia cial l servi vices ces and d marketin ting sectors

  • rs

skill illed ed in n entrepr epreneu eneursh rship, p, ventur ure capi pital al, public ublic and d priv ivate e equi uity, , foreign ign exchange hange, , optio ptions ns and nd as asset set manag agem ement.

  • ent. CEO

EO and d found nder er of G f GCI Corpo rpora ration, tion, a vertic icall ally y integrat egrated ed cannab nnabis s company any. . Bruce ce Campb pbell ell Portfolio Manager 24+ + years rs of i f inves estment ent manage agement ent experie erience nce and d an activ ive e cannabis nnabis inves estor

  • r since

ince 2013 013. Founde under r and d Portfol

  • lio Mana

nager ger of f Sto tone e Cas astle tle Inves estment ent Mana nage gement ent Paul Andersen, CPA, CA Director & CFO

Over 20 years of experience as a senior officer and/or director of numerous public and private. Cannabis-specific experience and currently serves as director of Canada House Wellness Group Inc., and has worked as a consultant with a privately owned Oregon-based cannabis company.

Nick J. Richards Independent Director

Practicing tax attorney, adjunct professor of law and legal specialist to the United States cannabis industry, advising businesses and owners throughout the U.S., and is licensed to practice law in California and Colorado.

Brayden Sutton Independent Director

Co-founded and served as EVP for Supreme Pharmaceuticals from 2013 – 2014 and played an instrumental role in the early days of Invictus MD Strategies Corp., Aurora Cannabis Inc. and CannaRoyalty Corp. Throughout his career, Mr. Sutton has played a major role in restructurings, reverse takeovers, IPOs and M&As

John Durfy Independent Director

25+ years of senior investment and financial management experience. Previously CIO at a hedge fund and prior to that, Managing Director of Global Equities for the Ontario Municipal Employees Retirement System (“OMERS”) from 2008-2011.

Gary Yeoman Independent Director

From 2005 to 2011, Mr. Yeoman served as the CEO of Altus Group, and led the company through a seven-year growth period. Previously Chairman of the board of Golden Leaf Holdings and Executive Chair of iLOOKABOUT.

Ja Jamie Blund undell ell Director, President & COO 25+ + years rs of e f experie erience ce in senior nior lead adersh ership ip roles es, , exte tensi nsive e experie erience ce with th M&A, , priv ivate e equit uity y fi firms and d large ge corpo pora rate e dives estit titur ures es.

slide-23
SLIDE 23

cgocorp.com 23

The CGOC Difference The Cannabis Growth Opportunity Corporation

Access to the knowledge and expertise needed to build and grow a diversified portfolio of public and private investments globally, to minimize downside risk, while participating in the long-term upside.

A portfolio of

Public Cannabis Businesses

  • Diversified to minimize downside
  • Actively managed
  • Global focus
  • ~60% of invested capital

A portfolio of

Private Cannabis Businesses

  • Unique access
  • Global focus
  • Target 12-24 month liquidity
  • ~40% of invested capital
slide-24
SLIDE 24

cgocorp.com 24

The Cannabis Industry Opportunity

Investing across the whole ecosystem multiplies the potential

  • $12B Canadian Cannabis industry estimate based on base market business models: cultivation and

extraction(1)

  • The whole ecosystem projected to reach $23B, after factoring in ancillary services shown below(2)

(1) Source: Latest Research reports from Cowen and Company (2) Source: Deloitte

Suppliers

Seeds, fertilizers, etc.

Production

Cultivation

Research and development

Extraction

Analytical equipment & services Production equipment, security & infrastructure Software

Retail and Distribution

Online / ecommerce Stores, consumption locations

Consumer Products

Flower and

  • il extracts

Edibles, tinctures, topicals, infused etc. Delivery Systems (vaporizers, pipes, rolling papers, etc.) Apparel Packaging & distribution

Services

Buildings, equipment Business, regulatory, legal, etc. Marketing Pharmaceuticals Nutraceuticals Fiber, seeds, food

Cannabinoid Therapeutics Finance Real Estate Hemp

Capital, structuring CGOC has also invested in

Traditional Industry

slide-25
SLIDE 25

cgocorp.com 25

Canada and the US

➢ A total of 33 states have legalized medicinal marijuana, and 10 states have legalized recreational use ➢ The US continues to be a driving force in production and consumption with California being the second largest market globally ➢ US MARKET SHARE alone expected to account for US$63 Billion at maturity

Upcoming Catalysts:

➢ The STATES Act, is expected to pass in 2019 – which will grant regulatory power to the individual states ➢ SAFE (Secure And Fair Enforcement) Banking act has 20 cosponsors in the Senate, and would protect banks and other institutions from federal prosecution when working with cannabis-related business.

US States Continue to Move Towards Legalization Canadian Developments

➢ Ahead of the legalization of extracted goods (such as edibles, vapes and infused beverages), many Canadian companies are in the midst of intense R&D and product roll out, as well as partnering with known brands in the US for supply control and brand recognition ➢ Canadian market expected to remain undersupplied until 2020

* source: Eight Capital

slide-26
SLIDE 26

cgocorp.com 26

The Global Picture

* source: Eight Capital

International Developments

➢ Medical Cannabis now officially regulated in over 50 countries world-wide, with more than 2 dozen of these centered within Europe ➢ Columbia and Israel have approved the exportation of cannabis ➢ Europe is opening up with many countries rapidly adapting their laws and adopting medical use cannabis GL GLOBA BAL CA L CANN NNABIS ABIS MARKE KET T an anti ticip ipated ed to

  • be w

e wor

  • rth

th US$ S$170 170 Bi Billio ion n ac acros

  • ss

a a 10-15 15 yea ear r ti time e hor

  • rizon

zon The e glob

  • bal

al lan andsc scape ape is ch chan anging ing rap apid idly, , crea eating ting com

  • mpeti

titi tion

  • n for
  • r con
  • ntr

trol

  • l of
  • f s

supply y

  • f
  • f b

both th THC HC an and CB CBD; p ; prop

  • prie

rietary tary ex extracti traction

  • n meth

thod

  • ds,

, rec ecipes pes an and for

  • rmula

mulas bei eing g rea eadil ily y sou

  • ught

ht af after er; ; an and on

  • ne

e of

  • f t

the e biggest est bran and d crea eati tion

  • n an

and rec ecogn

  • gnit

itio ion n battl tles es

  • f
  • f al

all ti time me.

slide-27
SLIDE 27

cgocorp.com 27

Staying Ahead of the Curve

Tech chni nicals ls Lead P d Pric ice

April 2018 January 2019 January 2019

Technicals - Time for a Rest?

Ap April il 2019 2019

slide-28
SLIDE 28

cgocorp.com 28

A Changing Environment Requires Continuous Monitoring of Information Keeping up to date on a fast-changing environment on the regulatory as well as investor sentiment side – We stay in the know!

Rapid regulatory change (local & global) Implication Key investing behaviors required to succeed: Active management, access to privates, timing investments US market attractiveness increasing Reasons Experienced operators + meaningful REV & EBITDA US capital is starting to increase rapidly Implication Need to focus & actively invest in US privates Privates need help navigating capital markets Implication Continue to focus and build capabilities to help privates access, navigate and succeed with the capital markets and M&A opportunities CGOC network effect working Implication Continue to connect investors, publics and privates and drive the CGOC network effect: trust